US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rapport Therapeutics, Inc.

29.50

-0.7000-2.32%

Post-market: 29.500.00000.00%16:10 EST

Volume:163.65K

Turnover:4.78M

Market Cap:1.41B

PE:-10.86

High:30.34

Open:30.34

Low:28.26

Close:30.20

52wk High:42.27

52wk Low:6.43

Shares:47.66M

Float Shares:26.57M

Volume Ratio:0.54

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7168

EPS(LYR):-3.7760

ROE:-23.41%

ROA:-15.89%

PB:2.75

PE(LYR):-7.81

Loading ...

Overview Company News Filings

Director Wendy B. Young Reports Acquisition of Common Shares in Rapport Therapeutics Inc

Rapport Therapeutics Inc. to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit

U.S. RESEARCH ROUNDUP-Chewy, Phillips 66, Vimeo

Rapport Therapeutics Announces Public Offering Agreement

Rapport Therapeutics Inc. Announces $234.7M Public Offering to Fund Clinical Trials

Cheryl Gault, COO of Rapport Therapeutics Inc., Reports Disposal of Common Shares

Biotech Company Rapport Plunges 18.8% Following Completion of $250 Million Public Offering

BUZZ-Rapport Therapeutics slips after $250 mln equity raise

BRIEF-Rapport Says Public Offering Of 9.6 Million Shares Of Its Common Stock At A Price Of $26.00 Per Share

Rapport Therapeutics Inc - Prices Public Offering at $26.00 per Share

THOMSON REUTERS

Rapport Therapeutics Inc: Public Offering of 9.6 Mln Shares of Its Common Stock at a Price of $26.00 per Share

THOMSON REUTERS

U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics

Rapport Therapeutics Inc : Jonestrading Raises Target Price to $50 From $42

THOMSON REUTERS

BUZZ-Rapport Therapeutics ticks up after commencing $250 mln equity offering

BRIEF-Rapport Announces Proposed Public Offering Of Common Stock

Rapport Therapeutics Announces Planned $250 Million Share Offering

MT Newswires Live

BRIEF-Rapport Therapeutics Terminates ATM Prospectus - SEC Filing

Rapport Therapeutics Inc. Announces $250 Million Public Offering of Common Stock

Rapport Announces Proposed Public Offering of Common Stock

THOMSON REUTERS

Rapport Therapeutics Inc - Announces $250 Mln Public Offering

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RAPP/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":29.5,"timestamp":1772139600000,"preClose":30.2,"halted":0,"volume":163645,"hourTrading":{"tag":"盘后","latestPrice":29.5,"preClose":29.5,"latestTime":"16:10 EST","volume":4990,"amount":147205.46407,"timestamp":1772140204334,"change":0,"changeRate":0,"amplitude":0.000339},"delay":0,"changeRate":-0.023178807947019844,"floatShares":26567199,"shares":47661138,"eps":-2.716762,"marketStatus":"Post-Mkt","change":-0.7,"latestTime":"02-26 18:59:19 EST","open":30.34,"high":30.34,"low":28.255,"amount":4776486.3756,"amplitude":0.06904,"askPrice":30.08,"askSize":66,"bidPrice":28.93,"bidSize":69,"shortable":3,"etf":0,"ttmEps":-2.716762,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":30.2,"postHourTrading":{"tag":"盘后","latestPrice":29.5,"preClose":29.5,"latestTime":"16:10 EST","volume":4990,"amount":147205.46407,"timestamp":1772140204334,"change":0,"changeRate":0,"amplitude":0.000339},"volumeRatio":0.535296,"impliedVol":1.0256,"impliedVolPercentile":0.7092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":26567199,"roa":"-15.89%","roe":"-23.41%","lyrEps":-3.775953,"volumeRatio":0.535296,"shares":47661138,"dividePrice":0,"high":30.34,"amplitude":0.06904,"preClose":30.2,"low":28.255,"week52Low":6.43,"pbRate":"2.75","week52High":42.2685,"institutionHeld":0,"latestPrice":29.5,"committee":0.022222,"eps":-2.716762,"divideRate":0,"volume":163645,"delay":0,"ttmEps":-2.716762,"open":30.34,"prevYearClose":30.34,"prevWeekClose":29.76,"prevMonthClose":26.61,"prevQuarterClose":30.34,"fiveDayClose":29.99,"twentyDayClose":26.44,"sixtyDayClose":29.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"RAPP","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-08-07","symbol":"RAPP","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2025-05-08","symbol":"RAPP","fiscalQuarterEnding":"2025/03","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2024-11-07","symbol":"RAPP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1771045200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2026-02-25","current":-10.858515,"percent":0.204176,"low":-19.654107,"twenty":-14.172361,"median":-11.478499,"eighty":-5.69117,"high":-3.640031,"avg":-10.448937,"sd":4.090439,"marketCap":1381696390},"quantilePoints":[{"date":"2024-06-07","current":-14.341434,"twenty":-13.293406,"median":-11.721364,"eighty":-11.721364,"marketCap":735830305},{"date":"2024-06-14","current":-17.322989,"twenty":-16.966549,"median":-15.024031,"eighty":-12.769392,"marketCap":888807905},{"date":"2024-06-21","current":-15.733266,"twenty":-17.881887,"median":-15.772475,"eighty":-14.348329,"marketCap":807242405},{"date":"2024-06-28","current":-16.581593,"twenty":-17.17471,"median":-16.18238,"eighty":-14.635158,"marketCap":850768389},{"date":"2024-07-05","current":-17.059223,"twenty":-17.829134,"median":-16.431888,"eighty":-15.672154,"marketCap":875274616},{"date":"2024-07-12","current":-18.299635,"twenty":-18.057796,"median":-16.595851,"eighty":-15.733266,"marketCap":938917651},{"date":"2024-07-19","current":-14.343149,"twenty":-18.092899,"median":-16.610109,"eighty":-15.733266,"marketCap":735918314},{"date":"2024-07-26","current":-16.431888,"twenty":-18.057796,"median":-16.50674,"eighty":-14.592658,"marketCap":843087333},{"date":"2024-08-02","current":-15.740395,"twenty":-18.021611,"median":-16.417631,"eighty":-14.614044,"marketCap":807608170},{"date":"2024-08-09","current":-11.062669,"twenty":-17.829134,"median":-16.189509,"eighty":-14.507112,"marketCap":697147270},{"date":"2024-08-16","current":-12.078391,"twenty":-17.822005,"median":-15.897228,"eighty":-14.341434,"marketCap":761156070},{"date":"2024-08-23","current":-12.943207,"twenty":-17.322989,"median":-15.776039,"eighty":-12.769083,"marketCap":815654991},{"date":"2024-08-30","current":-12.623979,"twenty":-17.301602,"median":-15.672154,"eighty":-12.252515,"marketCap":795537939},{"date":"2024-09-06","current":-11.799793,"twenty":-17.107699,"median":-14.956226,"eighty":-12.030797,"marketCap":743599370},{"date":"2024-09-13","current":-11.027844,"twenty":-17.007896,"median":-14.603351,"eighty":-11.813723,"marketCap":694952683},{"date":"2024-09-20","current":-12.322165,"twenty":-16.6871,"median":-14.421566,"eighty":-11.752199,"marketCap":776518182},{"date":"2024-09-27","current":-12.380206,"twenty":-16.587296,"median":-14.342291,"eighty":-11.752199,"marketCap":780175827},{"date":"2024-10-04","current":-12.072587,"twenty":-16.581593,"median":-13.041877,"eighty":-11.742318,"marketCap":760790305},{"date":"2024-10-11","current":-12.798103,"twenty":-16.461829,"median":-12.783593,"eighty":-11.721364,"marketCap":806510876},{"date":"2024-10-18","current":-15.061713,"twenty":-16.461829,"median":-13.041877,"eighty":-11.742318,"marketCap":949159059},{"date":"2024-10-25","current":-14.057599,"twenty":-16.431888,"median":-14.106934,"eighty":-11.752199,"marketCap":885881788},{"date":"2024-11-01","current":-14.289764,"twenty":-16.420482,"median":-14.289764,"eighty":-11.78122,"marketCap":900512371},{"date":"2024-11-08","current":-13.587752,"twenty":-16.360601,"median":-14.196898,"eighty":-11.792828,"marketCap":976225637},{"date":"2024-11-15","current":-10.665545,"twenty":-16.293733,"median":-13.709352,"eighty":-11.752199,"marketCap":766276774},{"date":"2024-11-22","current":-11.755009,"twenty":-16.213426,"median":-13.641207,"eighty":-11.719637,"marketCap":844550392},{"date":"2024-11-29","current":-11.627735,"twenty":-16.188083,"median":-13.405914,"eighty":-11.573511,"marketCap":835406277},{"date":"2024-12-06","current":-10.416089,"twenty":-16.139607,"median":-12.943207,"eighty":-11.450385,"marketCap":748354310},{"date":"2024-12-13","current":-9.555718,"twenty":-15.982774,"median":-12.73716,"eighty":-11.371152,"marketCap":686540097},{"date":"2024-12-20","current":-9.199351,"twenty":-15.858733,"median":-12.415031,"eighty":-11.254059,"marketCap":660936577},{"date":"2024-12-27","current":-9.688083,"twenty":-15.824515,"median":-12.350651,"eighty":-11.045256,"marketCap":696049976},{"date":"2025-01-03","current":-9.917175,"twenty":-15.797425,"median":-12.316361,"eighty":-10.975704,"marketCap":712509382},{"date":"2025-01-10","current":-7.539701,"twenty":-15.740395,"median":-12.304752,"eighty":-10.859002,"marketCap":541697328},{"date":"2025-01-17","current":-6.460419,"twenty":-15.733266,"median":-12.215086,"eighty":-10.644772,"marketCap":464155239},{"date":"2025-01-24","current":-7.076424,"twenty":-15.684376,"median":-12.087097,"eighty":-10.43238,"marketCap":508412752},{"date":"2025-01-31","current":-8.354253,"twenty":-15.597056,"median":-11.915876,"eighty":-10.137105,"marketCap":600219659},{"date":"2025-02-07","current":-8.211706,"twenty":-15.257893,"median":-11.843324,"eighty":-9.686047,"marketCap":589978251},{"date":"2025-02-14","current":-8.094614,"twenty":-15.103195,"median":-11.828814,"eighty":-9.441681,"marketCap":581565666},{"date":"2025-02-21","current":-6.455328,"twenty":-15.070846,"median":-11.799793,"eighty":-9.297098,"marketCap":463789474},{"date":"2025-02-28","current":-5.106225,"twenty":-15.037336,"median":-11.771597,"eighty":-9.077168,"marketCap":366861863},{"date":"2025-03-07","current":-4.373128,"twenty":-15.01412,"median":-11.747556,"eighty":-8.771711,"marketCap":314191765},{"date":"2025-03-14","current":-4.898381,"twenty":-14.977526,"median":-11.717047,"eighty":-8.416363,"marketCap":383577552},{"date":"2025-03-21","current":-4.530187,"twenty":-14.817535,"median":-11.627735,"eighty":-8.164869,"marketCap":354745367},{"date":"2025-03-28","current":-4.68399,"twenty":-14.676319,"median":-11.461087,"eighty":-7.790176,"marketCap":366789191},{"date":"2025-04-04","current":-4.189957,"twenty":-14.640334,"median":-11.410917,"eighty":-7.133443,"marketCap":328102968},{"date":"2025-04-11","current":-4.315796,"twenty":-14.632186,"median":-11.370643,"eighty":-6.989878,"marketCap":337957006},{"date":"2025-04-17","current":-4.730597,"twenty":-14.622599,"median":-11.327444,"eighty":-6.74653,"marketCap":370438835},{"date":"2025-04-25","current":-4.949801,"twenty":-14.60549,"median":-11.189913,"eighty":-6.457364,"marketCap":387604034},{"date":"2025-05-02","current":-5.280719,"twenty":-14.55844,"median":-11.048158,"eighty":-5.528775,"marketCap":413517298},{"date":"2025-05-09","current":-4.693792,"twenty":-14.472894,"median":-10.976093,"eighty":-5.332796,"marketCap":374099938},{"date":"2025-05-16","current":-4.560992,"twenty":-14.4176,"median":-10.940782,"eighty":-5.2164,"marketCap":363515647},{"date":"2025-05-23","current":-5.092192,"twenty":-14.397354,"median":-10.8247,"eighty":-5.097805,"marketCap":405852811},{"date":"2025-05-30","current":-3.896992,"twenty":-14.370288,"median":-10.665545,"eighty":-4.981023,"marketCap":310594193},{"date":"2025-06-06","current":-5.646289,"twenty":-14.346875,"median":-10.527934,"eighty":-4.950803,"marketCap":450014853},{"date":"2025-06-13","current":-5.101351,"twenty":-14.342806,"median":-10.416089,"eighty":-4.981023,"marketCap":406582762},{"date":"2025-06-20","current":-5.050978,"twenty":-14.341434,"median":-10.309179,"eighty":-5.014344,"marketCap":402568031},{"date":"2025-06-27","current":-5.408165,"twenty":-14.289764,"median":-9.866266,"eighty":-5.000606,"marketCap":431036124},{"date":"2025-07-03","current":-5.513507,"twenty":-14.247974,"median":-9.698265,"eighty":-5.011596,"marketCap":439432031},{"date":"2025-07-11","current":-7.043002,"twenty":-14.172521,"median":-9.586263,"eighty":-5.043651,"marketCap":561334272},{"date":"2025-07-18","current":-6.795718,"twenty":-14.077333,"median":-9.430989,"eighty":-5.078884,"marketCap":541625526},{"date":"2025-07-25","current":-7.610838,"twenty":-13.779001,"median":-9.362262,"eighty":-5.090926,"marketCap":606591391},{"date":"2025-08-01","current":-6.57591,"twenty":-13.6976,"median":-9.168805,"eighty":-5.092192,"marketCap":524106641},{"date":"2025-08-08","current":-6.368661,"twenty":-13.694662,"median":-9.054259,"eighty":-5.099519,"marketCap":562429202},{"date":"2025-08-15","current":-6.17446,"twenty":-13.609134,"median":-8.982986,"eighty":-5.10525,"marketCap":545278924},{"date":"2025-08-22","current":-6.170327,"twenty":-13.473486,"median":-8.4968,"eighty":-5.115317,"marketCap":544913945},{"date":"2025-08-29","current":-6.943168,"twenty":-13.38251,"median":-8.407708,"eighty":-5.122916,"marketCap":613165056},{"date":"2025-09-05","current":-6.343907,"twenty":-13.171889,"median":-8.282979,"eighty":-5.126995,"marketCap":560243072},{"date":"2025-09-12","current":-9.588184,"twenty":-13.020376,"median":-8.364435,"eighty":-5.143059,"marketCap":846751744},{"date":"2025-09-19","current":-14.281097,"twenty":-13.398113,"median":-8.486618,"eighty":-5.165131,"marketCap":1261192245},{"date":"2025-09-26","current":-13.038354,"twenty":-13.650327,"median":-8.934622,"eighty":-5.176938,"marketCap":1151443158},{"date":"2025-10-03","current":-14.902468,"twenty":-13.718742,"median":-9.051713,"eighty":-5.195691,"marketCap":1316066789},{"date":"2025-10-10","current":-13.962579,"twenty":-13.896787,"median":-9.158623,"eighty":-5.223161,"marketCap":1233063277},{"date":"2025-10-17","current":-12.986138,"twenty":-13.856058,"median":-9.228454,"eighty":-5.262092,"marketCap":1146831851},{"date":"2025-10-24","current":-13.675391,"twenty":-13.856058,"median":-9.397898,"eighty":-5.294604,"marketCap":1207701093},{"date":"2025-10-31","current":-14.035682,"twenty":-13.934383,"median":-9.502263,"eighty":-5.303959,"marketCap":1239519106},{"date":"2025-11-07","current":-11.969573,"twenty":-13.970933,"median":-9.588184,"eighty":-5.319746,"marketCap":1169427252},{"date":"2025-11-14","current":-12.034803,"twenty":-13.934383,"median":-9.698265,"eighty":-5.33408,"marketCap":1175800274},{"date":"2025-11-21","current":-13.098276,"twenty":-13.915585,"median":-9.917175,"eighty":-5.342242,"marketCap":1279701555},{"date":"2025-11-28","current":-14.493474,"twenty":-13.931568,"median":-10.309179,"eighty":-5.356195,"marketCap":1416012409},{"date":"2025-12-05","current":-14.000764,"twenty":-13.954437,"median":-10.426271,"eighty":-5.376155,"marketCap":1367874660},{"date":"2025-12-12","current":-14.039791,"twenty":-13.99491,"median":-10.604143,"eighty":-5.393122,"marketCap":1371687551},{"date":"2025-12-19","current":-14.459326,"twenty":-14.050476,"median":-10.719003,"eighty":-5.431972,"marketCap":1412676130},{"date":"2025-12-26","current":-15.088628,"twenty":-14.119227,"median":-10.841851,"eighty":-5.476848,"marketCap":1474158998},{"date":"2026-01-02","current":-14.800808,"twenty":-14.281097,"median":-10.940782,"eighty":-5.513507,"marketCap":1446038926},{"date":"2026-01-09","current":-13.81051,"twenty":-14.281097,"median":-10.976093,"eighty":-5.513507,"marketCap":1349286816},{"date":"2026-01-16","current":-13.103154,"twenty":-14.237527,"median":-11.048158,"eighty":-5.513507,"marketCap":1280178166},{"date":"2026-01-23","current":-13.620256,"twenty":-14.172521,"median":-11.156822,"eighty":-5.535473,"marketCap":1330698972},{"date":"2026-01-30","current":-13.049493,"twenty":-14.13499,"median":-11.312246,"eighty":-5.592253,"marketCap":1274935441},{"date":"2026-02-06","current":-12.464095,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"marketCap":1217742075},{"date":"2026-02-13","current":-13.644647,"twenty":-14.087483,"median":-11.410917,"eighty":-5.641114,"marketCap":1333082029},{"date":"2026-02-20","current":-14.630067,"twenty":-14.14031,"median":-11.45735,"eighty":-5.660027,"marketCap":1429357528},{"date":"2026-02-25","current":-14.142235,"twenty":-14.172361,"median":-11.478499,"eighty":-5.69117,"marketCap":1381696390}],"updateTime":1772147881008},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566126499","title":"Director Wendy B. Young Reports Acquisition of Common Shares in Rapport Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2566126499","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566126499?lang=en_us&edition=fundamental","pubTime":"2025-09-12 06:14","pubTimestamp":1757628868,"startTime":"0","endTime":"0","summary":"Wendy B. Young, a Director at Rapport Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL8xcSSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Wendy B. Young Reports Acquisition of Common Shares in Rapport Therapeutics Inc","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2566195879","title":"Rapport Therapeutics Inc. to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2566195879","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566195879?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:05","pubTimestamp":1757621132,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Inc., a clinical-stage biotechnology company focused on developing precision medicines for neurological and psychiatric disorders, will participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. The virtual event will feature a fireside chat with Rapport's management on Wednesday, September 17, 2025, at 11:20 am ET. Interested parties can access the live and archived webcast of the chat via the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on September 11, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL1nd2j0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","NDAQ"],"gpt_icon":0},{"id":"2566527549","title":"U.S. RESEARCH ROUNDUP-Chewy, Phillips 66, Vimeo","url":"https://stock-news.laohu8.com/highlight/detail?id=2566527549","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566527549?lang=en_us&edition=fundamental","pubTime":"2025-09-11 15:57","pubTimestamp":1757577456,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Chewy, Phillips 66, Vimeo Sept 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Chewy, Phillips ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nL3N3UY0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4200","LU0757428866.USD","LU0266512127.USD","LU1267930227.SGD","RAPP","BK4138","LU1559883803.SGD","MNSH","LU0368265418.SGD","LU0980610538.SGD","DK","BK4585","BK4023","FROG","LU1941712264.USD","LU0310800965.SGD","BK4139","BK4221","LU0345780950.USD","LU1941712348.USD","NEUP","BK4113","IE00B3CCJ963.GBP","LU1169589451.USD","IE00B2Q91V27.USD","BK4084","PBF","DINO","CHWY","LU1169590202.USD","PARR","PSX","VMEO","CASY","RBRK","IE00B3T34201.USD","MPC","LU0130517989.USD","BK4202","TPR","IE00BGHQF524.EUR","LU0130102774.USD","WK","VLO","WY","LU0566484027.USD","CAMP","LU0208291251.USD","IE0009354923.USD"],"gpt_icon":0},{"id":"2566762980","title":"Rapport Therapeutics Announces Public Offering Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2566762980","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566762980?lang=en_us&edition=fundamental","pubTime":"2025-09-11 05:51","pubTimestamp":1757541076,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. ( ($RAPP) ) just unveiled an update. On September 9, 2025, Rapport Therapeutics, Inc. entered into an underwriting agree...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-announces-public-offering-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rapport-therapeutics-announces-public-offering-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2566980846","title":"Rapport Therapeutics Inc. Announces $234.7M Public Offering to Fund Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2566980846","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566980846?lang=en_us&edition=fundamental","pubTime":"2025-09-11 05:23","pubTimestamp":1757539395,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. has entered into an Underwriting Agreement with Goldman Sachs & Co. LLC, Jefferies LLC, TD Securities  LLC, and Stifel, Nicolaus & Company, Incorporated for a public offering of 9,615,385 shares of its common stock. Priced at $26.00 per share, the offering is expected to generate approximately $234.7 million in net proceeds, excluding potential additional shares the underwriters may purchase. The funds will be used to support ongoing and planned clinical trials, research and development initiatives, and general corporate purposes. The offering is anticipated to close around September 11, 2025, pending customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. publis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL44RL3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0061475181.USD","BK4504","IE0004086264.USD","LU2237443622.USD","LU1868836757.USD","IE0004091025.USD","LU1868837136.USD","LU1868837300.USD","LU2237443382.USD","IE0034235188.USD","IE0002270589.USD","LU2237438978.USD","LU2471134879.HKD","BK4007","BK4588","LU2237443978.SGD","LU1894683348.USD","LU2750360997.AUD","BK4516","LU2237443465.HKD","SF","BK4127","IE00B19Z3B42.SGD","LU0251131958.USD","LU2237443549.SGD","LU2237443895.HKD","BK4585","LU0048573561.USD","LU0742534661.SGD","LU1668664300.SGD","IE00BFXG1179.USD","BK4552","LU2471134952.CNY","LU2265009873.SGD","LU2750360641.GBP","LU1804176565.USD","BK4559","LU0251142724.SGD","BK4550","RAPP","LU0106831901.USD","IE00BSNM7G36.USD","LU1894683264.USD","JEF","LU2471134796.USD","BK4533","LU1791807156.HKD","LU2471134523.USD","LU1868836591.USD"],"gpt_icon":0},{"id":"2566079984","title":"Cheryl Gault, COO of Rapport Therapeutics Inc., Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2566079984","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566079984?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:15","pubTimestamp":1757535342,"startTime":"0","endTime":"0","summary":"Cheryl Gault, Chief Operating Officer of Rapport Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nNDL59yCgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"1117546794","title":"Biotech Company Rapport Plunges 18.8% Following Completion of $250 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=1117546794","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117546794?lang=en_us&edition=fundamental","pubTime":"2025-09-10 23:00","pubTimestamp":1757516459,"startTime":"0","endTime":"0","summary":"In early Wednesday trading, Rapport Therapeutics, Inc. (RAPP), a biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) diseases, saw its stock price...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNS","BK4135","RAPP"],"gpt_icon":0},{"id":"2566167722","title":"BUZZ-Rapport Therapeutics slips after $250 mln equity raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2566167722","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566167722?lang=en_us&edition=fundamental","pubTime":"2025-09-10 18:28","pubTimestamp":1757500137,"startTime":"0","endTime":"0","summary":"** Rapport Therapeutics' RAPP.O shares down 2.5% to $27.34 before the bell after follow-on offering priced. ** Co late Tues announced ~9.6 mln shares at $26 for $250 mln gross proceeds. ** Offering price represents 7.2% discount to stock's last close. RAPP shares on Mon soared ~119% to close at $31.47 after its seizure drug, RAP-219, met mid-stage trial goals. ** Its shares fell nearly 11% on Tues after co commenced the offering. to primarily fund ongoing and planned clinical trials advancing RAP-219, other R&D and for working capital and other purposes, per the prospectus filing. ** Goldman Sachs, Jefferies, TD Cowen and Stifel are joint bookrunners for the offering. ** Boston-headquartered Rapport has ~36.5 mln shares outstanding for ~$1 bln current market cap. ** Rapport, backed by Johnson & Johnson JNJ.N, went public in Jun 2024 after IPO priced at $17. ** All 6 analysts are bullish on RAPP; median PT of $50 up from $35 a month ago, per LSEG data","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nL6N3UX0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032955483.USD","JNJ","LU1221951046.USD","LU0203347892.USD","LU2471134952.CNY","SF","LU2237438978.USD","BK4504","LU0106831901.USD","IE0034235303.USD","LU1674673428.USD","LU0289739699.SGD","LU0640476718.USD","LU1668664300.SGD","LU1868836591.USD","LU2112291526.USD","RAPP","LU1066051498.USD","IE00BLSP4239.USD","LU0985320562.USD","LU1929549753.HKD","LU1066053197.SGD","IE00B19Z3581.USD","LU1506573853.SGD","IE00BVYPNW00.USD","LU1057294990.SGD","LU0122379950.USD","LU1244550577.SGD","IE00B3PB1722.GBP","LU1804176565.USD","LU2592432038.USD","SG9999001440.SGD","IE0009355771.USD","LU2237443622.USD","LU2237443978.SGD","LU1732799900.SGD","BK4585","LU0912757837.SGD","LU1430594728.SGD","IE00BN8TJ469.HKD","BK4592","IE00B1BXHZ80.USD","LU0320765646.SGD","IE0004091025.USD","LU2237443549.SGD","LU2129689605.HKD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0345769128.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"2566640111","title":"BRIEF-Rapport Says Public Offering Of 9.6 Million Shares Of Its Common Stock At A Price Of $26.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2566640111","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566640111?lang=en_us&edition=fundamental","pubTime":"2025-09-10 09:20","pubTimestamp":1757467251,"startTime":"0","endTime":"0","summary":"BRIEF-Rapport Says Public Offering Of 9.6 Million Shares Of Its Common Stock At A Price Of $26.00 Per ShareSept 9 (Reuters) - Rapport Therapeutics Inc RAPP.O:RAPPORT ANNOUNCES PRICING OF PUBLIC OFFERI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA2Z7QRQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2566640608","title":"Rapport Therapeutics Inc - Prices Public Offering at $26.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2566640608","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566640608?lang=en_us&edition=fundamental","pubTime":"2025-09-10 09:17","pubTimestamp":1757467038,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA2Z7QRQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2566064067","title":"Rapport Therapeutics Inc: Public Offering of 9.6 Mln Shares of Its Common Stock at a Price of $26.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2566064067","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566064067?lang=en_us&edition=fundamental","pubTime":"2025-09-10 09:17","pubTimestamp":1757467038,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nTUA2Z7QRQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2566664517","title":"U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2566664517","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566664517?lang=en_us&edition=fundamental","pubTime":"2025-09-09 15:29","pubTimestamp":1757402941,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United TherapeuticsSept 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL3N3UW0GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS","LU0320765992.SGD","TASK","SGXZ51526630.SGD","WING","LU1791807156.HKD","BK4127","MEDP","BMI","LU0081259029.USD","BK4108","FDS","LU1720051017.SGD","BK4606","LU2360106780.USD","PIPR","LU2458330169.SGD","SATS","CRL","BK4121","UTHR","SEE","RAPP","IQV","BK4204","INSM","BAC","CEG","FTRE","EPAM","IE00B0169N27.USD","RS","HSY","LU0390134368.USD","ELF","LU0047713382.USD","SRPT","CMG","TKO","APEI","BK4614","IE00B19Z3B42.SGD","EMN","LU0098860793.USD","LU0823434583.USD","LU1242518857.USD","LU1861220207.SGD","BK4179"],"gpt_icon":1},{"id":"2566668857","title":"Rapport Therapeutics Inc : Jonestrading Raises Target Price to $50 From $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2566668857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566668857?lang=en_us&edition=fundamental","pubTime":"2025-09-09 12:17","pubTimestamp":1757391471,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2566563779","title":"BUZZ-Rapport Therapeutics ticks up after commencing $250 mln equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566563779","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566563779?lang=en_us&edition=fundamental","pubTime":"2025-09-09 05:25","pubTimestamp":1757366718,"startTime":"0","endTime":"0","summary":"extended trading as co looks to raise equity after its stock soared. ** RAPP shares on Mon closed up ~119% at $31.47 after its seizure drug, RAP-219, met mid-stage trial goals. ** After the bell, co commences $250 mln stock offering. ** It intends to use net proceeds to primarily fund ongoing and planned clinical trials advancing RAP-219, other R&D and for working capital and other purposes, per the prospectus filing. ** Goldman Sachs, Jefferies, TD Cowen and Stifel are joint bookrunners. ** Boston-headquartered Rapport has ~36.5 mln shares outstanding for ~$1.1 bln current market cap. ** Rapport, backed by Johnson & Johnson JNJ.N, went public in Jun 2024 after IPO priced at $17. ** All 6 analysts are bullish on RAPP; median PT of $50 up from $35 a month ago, per LSEG data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nL6N3UV11R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU1221951046.USD","IE0004091025.USD","LU2430703251.USD","LU1032466523.USD","LU1430594728.SGD","IE00BGHQF631.EUR","BK4007","LU2237443465.HKD","LU0882574055.USD","LU0345770308.USD","LU1506573853.SGD","IE00BDGV0183.EUR","LU1674673691.USD","LU1868837300.USD","IE00B7SZLL34.SGD","LU1868836757.USD","LU0795875086.SGD","LU2237443382.USD","BK4588","IE00B3T34201.USD","IE00BN8TJ469.HKD","IE00B3PB1722.GBP","LU0203345920.USD","LU1668664300.SGD","LU2750360641.GBP","BK4552","LU1066053197.SGD","LU2468319806.SGD","LU0742534661.SGD","LU1674673428.USD","LU2471134879.HKD","LU2430703178.SGD","IE0034235303.USD","IE00B19Z3B42.SGD","RAPP","SF","IE0004086264.USD","LU2237443549.SGD","JNJ","IE00BVYPNW00.USD","LU1585245621.USD","LU0122379950.USD","LU2237438978.USD","LU1066051498.USD","LU2265009873.SGD","LU2471134952.CNY","LU0795875169.SGD","IE0002270589.USD","LU1267930813.SGD"],"gpt_icon":0},{"id":"2566882637","title":"BRIEF-Rapport Announces Proposed Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2566882637","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566882637?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:47","pubTimestamp":1757364458,"startTime":"0","endTime":"0","summary":"BRIEF-Rapport Announces Proposed Public Offering Of Common StockSept 8 (Reuters) - Rapport Therapeutics Inc RAPP.O:RAPPORT ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCKRAPPORT THERAPEUTICS INC - ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA5C1BNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2566632539","title":"Rapport Therapeutics Announces Planned $250 Million Share Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566632539","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566632539?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:22","pubTimestamp":1757362964,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics (RAPP) said Monday it started an underwritten public offering of $250 million of shares, subject to market conditions.Underwriters will be given a 30-day option to buy up to an ad","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4539","BK4007","BK4139","RAPP"],"gpt_icon":0},{"id":"2566634788","title":"BRIEF-Rapport Therapeutics Terminates ATM Prospectus - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2566634788","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566634788?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:09","pubTimestamp":1757362152,"startTime":"0","endTime":"0","summary":"BRIEF-Rapport Therapeutics Terminates ATM Prospectus - SEC FilingSept 8 (Reuters) - Rapport Therapeutics Inc RAPP.O:RAPPORT THERAPEUTICS INC - TERMINATES ATM PROSPECTUS - SEC FILINGSource text: [ID:n0001193125-25-198322]Further company coverage: RAPP.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV1EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2566634265","title":"Rapport Therapeutics Inc. Announces $250 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2566634265","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566634265?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361936,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Inc., a clinical-stage biotechnology company focused on developing small molecule precision medicines for neurological and psychiatric disorders, has announced a public offering of $250 million in common stock. The offering, which is subject to market and other conditions, will be underwritten by Goldman Sachs & Co. LLC, Jefferies, TD Cowen, and Stifel, acting as joint book-running managers. Rapport also plans to grant underwriters a 30-day option to purchase an additional $37.5 million in shares at the public offering price, excluding underwriting discounts and commissions. The offering will be conducted under an effective shelf registration statement filed with the U.S. Securities and Exchange Commission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL7mt2X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","LU2237443382.USD","LU0251131958.USD","LU2095319765.USD","LU0061475181.USD","LU0742534661.SGD","LU2210150020.SGD","BK4585","LU2237443465.HKD","LU0314104364.USD","LU1894683264.USD","IE00BGHQF748.EUR","LU2237443622.USD","LU2471134523.USD","IE0034235188.USD","LU1804176565.USD","LU2750360997.AUD","LU2210149790.SGD","LU2471134879.HKD","NDAQ","IE00B64PRP62.GBP","IE00BSNM7G36.USD","LU0251142724.SGD","IE0004086264.USD","BK4127","IE00B19Z3581.USD","LU2750360641.GBP","LU0106831901.USD","LU1668664300.SGD","LU1868836591.USD","LU1868837136.USD","LU1791807156.HKD","LU2237443895.HKD","IE0004091025.USD","BK4588","LU1868836757.USD","BK4552","LU0048573561.USD","BK4112","BK4550","BK4516","LU1868837300.USD","RAPP","LU2471134796.USD","IE00BFXG1179.USD","LU0096364046.USD","LU1868836914.USD","LU2237443549.SGD","BK4504","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2566963448","title":"Rapport Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2566963448","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566963448?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA5C1BNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2566634406","title":"Rapport Therapeutics Inc - Announces $250 Mln Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2566634406","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566634406?lang=en_us&edition=fundamental","pubTime":"2025-09-09 04:05","pubTimestamp":1757361900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA5C1BNW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":102,"code":"91000000","status":"200"}]}}